MSB 2.51% 97.0¢ mesoblast limited

Ann: Remestemcel-L Improves Outcomes in Inflammatory Lung Disease, page-24

  1. 405 Posts.
    lightbulb Created with Sketch. 39
    This is amazing !!!! Well done MSB team!! Bravo
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.